Smart Inhalers Market

Smart Inhalers Market By Product Type (Dry Powder Inhaler, Metered-Dose Inhaler), By Device Type (Built In Smart Inhaler, Attach Type Smart Inhaler), By Indication (Asthma, Chronic Obstructive Pulmonary Disorders [COPD], And Others), By Geography is anticipated to grow at a static CAGR forecast till 2026 owing to rising prevalence of chronic respiratory disorders and increasing acceptance towards digital healthcare equipment.

 

Global Smart Inhalers Market was valued at USD XX billion in 2020, growing at a CAGR of 21.26% during the forecast period from 2021 to 2026 to reach USD XX billion by 2026. The rise in demand for Smart Inhalers is primarily attributed to the growing prevalence of various respiratory disorders such as asthma, COPD, rising burden of air pollution across the globe. Moreover, the adoption of digital technology by key pharmaceutical players to provide better solutions for respiratory disorder management as well as increasing awareness related to connective devices in developing nations is also expected to boost the market for smart inhalers.

Smart Inhalers Market Dynamics:

Smart inhalers are devices designed to connect to the mobile application through Bluetooth for proper management of chronic respiratory disorders and improved patient lifestyle. The surge in the demand for smart inhalers has increased exponentially due to the rising prevalence of respiratory diseases such as asthma, cystic fibrosis, chronic obstructive pulmonary disorders, among others. According to the WHO 2021 report, asthma is a major noncommunicable disease (NCD), affecting both children and adults, and has affected an estimated 262 million people in 2019 and caused 461000 deaths in the same year. Also, the report stated that most asthma-related deaths occur in low- and lower-middle-income countries, where under-diagnosis and under-treatment are a challenge. Moreover, as per the data from the 2017–18 Australian Bureau of Statistics (ABS) National Health Survey (NHS) (ABS 2018), around 2.7 million Australians (one in nine or 11.2% of the total population) have asthma. The rising cases of asthma will directly contribute to the global market for smart inhalers as these inhalers help relax muscles and opens the airway allowing more air move in and out of the lungs for easy and comfortable breathing.

 

Rising global urbanization has led to a steady increase in respiratory illness owing to increasing pollution, rise in the adoption of sedentary lifestyles such as smoking which also leads to second-hand inhalation, may also contribute to the market growth for smart inhalers. According to WHO 2021 report, approximately 91% of the world population in the year 2016 lived in places where air quality exceeds WHO guideline limits. Rising air pollution is found to increase the risk of respiratory infections. Thus, as per the above mentioned factors, it is anticipated that the market for smart inhalers will increase in the forecast period.

 

Furthermore, smart inhalers are digitally advanced than normal inhalers and provide many benefits over normal inhalers such as improved therapy outcome, prevent erroneous inhaker use, among others. Thus, in the era of digitalization, smart inhalers sales will increase in the forecast period.

 

However, certain factors such as the high cost of the smart inhalers and availability of substitute manual inhalers may pose a minor hurdle for the growth of the Smart Inhalers market.

Smart Inhalers Segment Analysis:

Smart Inhalers Market By Product Type (Dry Powder Inhaler (DPI), Metered-Dose Inhaler (MDI), By Device Type (Built In Smart Inhaler, Attach Type Smart Inhaler), By Indication (Asthma, Chronic Obstructive Pulmonary Disorders [COPD], and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

 

In the Smart Inhalers product segment, the metered-dose inhaler (MDI segment is expected to dominate the market during the forecasted period. This is owing to the various advantages associated with these inhalers such as MDIs are not breath activated, are cost-effective, and provide accuracy in drug dosage to help assist in controlling and monitoring drug amounts to be dispersed as per the requirement.

 

Additionally, product approvals for technologically advanced MDI-based smart inhalers are further projected to propel the market. For instance, recently in January 2020, Cognita Labs, a respiratory technologies company, received the US Food and Drug Administration (FDA) clearance for CapMedic, the world's first interactive digital inhaler sensor for MDI, which can measure inhaler use with high granularity. Cognita’s CapMedic provides real-time audio-visual interactive guidance on the correct use of inhalers and also measures the correctness of inhaler use, time, and frequency of its use.

 

Therefore, the aforementioned factors are likely to propel the segmental growth of the Smart Inhalers market.

North America is expected to dominate the overall Smart Inhalers Market:

Among all the countries, North America is anticipated to dominate the overall Smart Inhalers market during the forecast period. This domination is due to the presence of established healthcare facilities, rising government initiatives, and support for raising awareness regarding respiratory disorders and their proper management in the region.

 

Further, in the United States, the rising smoking, increasing COPD a chronic respiratory disorder is likely to fuel the smart inhalers market in the region. For instance, as per the CDC 2019 report, nearly 14 of every 100 US adults aged 18 years or older (14.0%) smoked cigarettes. This means an estimated 34.1 million adults in the United States currently smoke cigarettes and more than 16 million Americans live with a smoking-related disease. Smoking is a major risk factor associated with the development of COPD disorder among the population. Also, based on the American Lung Association data, in 2018, 16.4 million people, or 6.6% of adults, reported a diagnosis of any type of COPD (chronic bronchitis, emphysema, or COPD). The COPD rates among adults ranged from 4.0% in Hawaii to 15.3% in West Virginia. In addition, according to the Canadian Tobacco and Nicotine Survey (CTNS) 2019 statistics, the prevalence of cigarette smoking in 2019 was 12% (3.7 million) and there was no difference in the prevalence of smoking between men (13% or 1.9 million) and women (11% or 1.7 million).

 

Moreover, recent product approvals in the region will further augment the market for smart inhalers in the region. For instance in July 2020, Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. launched ProAir® Digihaler® (albuterol sulfate 117 mcg) Inhalation Powder for Patients with Asthma and COPD.

 

Furthermore, Europe and Asia-Pacific region have the future potential growth for the Global Smart Inhalers. The presence of key players such as GlaxoSmithKline, AstraZeneca, and Teva pharmaceuticals, among others is likely to drive the market. Moreover, an increase in disposable income, rapid urbanization, integration of IOT and digitilization in the healthcare system along with the acceptances of smart devices in the region are the factors that are likely to drive the market for smart inhalers.

Smart Inhalers Market Key Players:

Some of the key market players operating in the Smart Inhalers market include Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline plc., AptarGroup, Inc., Novartis AG, OPKO Health, Inc., BreatheSuite Inc.,  adherium, Propeller Health, H&T Presspart Manufacturing Ltd., Zeolr Technologies Pvt Ltd , Findair Sp. z o. o., Lupin, Personal Air Quality Systems Pvt Ltd (PAQS), Biocorp, Cognita Labs, and others.

Recent Developmental Activities in the Smart Inhalers Market:

  • In August 2020, Propeller Health collaborated with Novartis to connect the Propeller digital health platform to Enerzair® and Atectura® Breezhaler to treat uncontrolled asthma and started the distribution of the product in Japan.
  • In June 2020, Aptar Pharma partnered with Lupin Limited to launch India’s first connected device for metered-dose inhalers (MDI) called ADHERO.

Key Takeaways from the Smart Inhalers Market Report Study

  • Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Smart Inhalers market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the Global Smart Inhalers Market.
  • Various opportunities available for the other competitor in the Smart Inhalers Market space.
  • What are the top-performing segments in 2020? How these segments will perform in 2026.
  • Which are the top-performing regions and countries in the current market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Smart Inhalers market growth in the coming future?

Target Audience who can be benefited from the Smart Inhalers Market Report Study

  • Smart Inhalers providers
  • Research organizations and consulting companies
  • Smart Inhalers-related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders in Smart Inhalers
  • Various End-users who want to know more about the Smart Inhalers Market and the latest technological developments in the Smart Inhalers market.

Frequently Asked Questions for the Smart Inhalers Market:

1. What are Smart Inhalers?

Smart inhalers are inhalers with extra digital features. These inhalers contain sensors that attach to existing inhalers or are integrated in the inhalers and record when the medication is taken. They are Bluetooth-enabled, so can be paired wirelessly with a smart device like a phone or tablet or with a computer to allow data to be transferred from the smart inhaler automatically.


2. What is the market for Global Smart Inhalers?

Global Smart Inhalers Market was valued at USD XX billion in 2020, growing at a CAGR of 21.26% during the forecast period from 2021 to 2026 to reach USD XX billion by 2026.

 

3. What are the drivers for Global Smart Inhalers?

The major factors driving the demand for Smart Inhalers are the growing prevalence of respiratory disorders such as asthma, COPD among the population, rise in collaboration between key pharmaceutical companies and digital health platforms providing companies, increasing level of air pollution, and awareness related to connected devices.

 

4. What are the key players operating in Global Smart Inhalers?

Some of the key market players operating in the Smart Inhalers market include Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline plc., AptarGroup, Inc., Novartis AG, OPKO Health, Inc., BreatheSuite Inc.,  adherium, Propeller Health, H&T Presspart Manufacturing Ltd., Zeolr Technologies Pvt Ltd , Findair Sp. z o. o., Lupin, Personal Air Quality Systems Pvt Ltd (PAQS), Biocorp, Cognita Labs, and others.

 

5. Which region has the highest share in Smart Inhalers Market?

North America is anticipated to dominate the overall Smart Inhalers market during the forecast period 2021-2026. This domination is due to the presence of established healthcare facilities, rising government initiatives, and support for raising awareness regarding respiratory disorders and their proper management in the region.

1. Smart Inhalers Report Introduction

2. Smart Inhalers Executive summary

2.1. Scope of the Study

2.2. Market at Glance

2.3. Competitive Assessment

2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

3.1. The United States

3.2. Europe

3.2.1. Germany

3.2.2. France

3.2.3. Italy

3.2.4. Spain

3.2.5. The U.K.

3.3. Japan

4. Smart Inhalers Market Key factors analysis

4.1. Smart Inhalers Market Drivers

4.1.1. The rise in the levels of pollution worldwide

4.1.2. Increase in the prevalence of respiratory disorders such as COPD and Asthma

4.1.3. Growing collaboration between pharma and digital health companies

4.1.4. Increase in awareness regarding connected device among developing nation

4.2. Smart Inhalers Market Restraints and Challenges

4.2.1. Limited availability of the device

4.2.2. Concerns Regarding Privacy

4.3. Smart Inhalers Market Opportunities

4.3.1. Growth opportunities among low-income countries

4.3.2. Increasing modernization and technological advancements

5. Smart Inhalers Porter’s Five Forces Analysis

5.1. Bargaining Power of Suppliers

5.2. Bargaining Power of Consumers

5.3. Threat of New Entrants

5.4. Threat of Substitutes

5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Smart Inhalers Market

7. Smart Inhalers Market layout

7.1. By Product Type

7.1.1. Dry Powder Inhaler (DPI) - based smart inhalers

7.1.2. Metered Dose Inhaler (MDI) - based smart inhalers

7.2. By Product Type

7.2.1. Built-in Smart Inhalers

7.2.2. Attach Type Smart Inhalers

7.3. By Indication

7.3.1. Asthma

7.3.2. COPD

7.3.3. Others

7.4. By Geography

7.4.1. North America

7.4.1.1. North America Smart Inhalers Market, by Product Type

7.4.1.2. North America Smart Inhalers Market, by Device Type

7.4.1.3. North America Smart Inhalers Market, by Indication

7.4.1.4. North America Smart Inhalers Market, by Country

7.4.1.4.1. United States

7.4.1.4.2. Canada

7.4.1.4.3. Mexico

7.4.2. Europe

7.4.2.1. Europe Smart Inhalers Market, by Product Type

7.4.2.2. Europe Smart Inhalers Market, by Device Type

7.4.2.3. Europe Smart Inhalers Market, by Indication

7.4.2.4. Europe Smart Inhalers Market, by Country

7.4.2.4.1. France

7.4.2.4.2. Germany

7.4.2.4.3. United Kingdom

7.4.2.4.4. Italy

7.4.2.4.5. Spain

7.4.2.4.6. Russia

7.4.2.4.7. Rest of Europe

7.4.3. Asia-Pacific

7.4.3.1. Asia-Pacific Smart Inhalers Market, by Product Type

7.4.3.2. Asia-Pacific Smart Inhalers Market, by Device Type

7.4.3.3. Asia-Pacific Smart Inhalers Market, by Indication

7.4.3.4. Asia-Pacific Smart Inhalers Market, by Country

7.4.3.4.1. China

7.4.3.4.2. Japan

7.4.3.4.3. India

7.4.3.4.4. Australia

7.4.3.4.5. South Korea

7.4.3.4.6. Rest of Asia Pacific

7.4.4. Rest of the World (RoW)

7.4.4.1. RoW Smart Inhalers Market, by Product Type

7.4.4.2. RoW Smart Inhalers Market, by Device Type

7.4.4.3. RoW Smart Inhalers Market, by Indication

7.4.4.4. RoW Smart Inhalers Market, by Region

7.4.4.4.1. Middle East

7.4.4.4.2. Africa

7.4.4.4.3. South America

8. Smart Inhalers Global Company Share Analysis – Key 3-5 Companies

9. Smart Inhalers Company and Product Profiles

9.1. AstraZeneca

9.1.1. Company Overview

9.1.2. Company Snapshot

9.1.3. Financial Overview

9.1.4. Product Listing

9.1.5. Entropy

9.2. OPKO Health, Inc.

9.2.1. Company Overview

9.2.2. Company Snapshot

9.2.3. Financial Overview

9.2.4. Product Listing

9.2.5. Entropy

9.3. Propeller Health.

9.3.1. Company Overview

9.3.2. Company Snapshot

9.3.3. Financial Overview

9.3.4. Product Listing

9.3.5. Entropy

9.4. adherium

9.4.1. Company Overview

9.4.2. Company Snapshot

9.4.3. Financial Overview

9.4.4. Product Listing

9.4.5. Entropy

9.5. H&T Presspart Manufacturing Ltd.

9.5.1. Company Overview

9.5.2. Company Snapshot

9.5.3. Financial Overview

9.5.4. Product Listing

9.5.5. Entropy

9.6. GlaxoSmithKline plc.

9.6.1. Company Overview

9.6.2. Company Snapshot

9.6.3. Financial Overview

9.6.4. Product Listing

9.6.5. Entropy

9.7. Zeolr Technologies Pvt Ltd 

9.7.1. Company Overview

9.7.2. Company Snapshot

9.7.3. Financial Overview

9.7.4. Product Listing

9.7.5. Entropy

9.8. Findair Sp. z o. o.

9.8.1. Company Overview

9.8.2. Company Snapshot

9.8.3. Financial Overview

9.8.4. Product Listing

9.8.5. Entropy

9.9. AptarGroup, Inc.

9.9.1. Company Overview

9.9.2. Company Snapshot

9.9.3. Financial Overview

9.9.4. Product Listing

9.9.5. Entropy

9.10. Teva Pharmaceutical Industries Ltd.

9.10.1. Company Overview

9.10.2. Company Snapshot

9.10.3. Financial Overview

9.10.4. Product Listing

9.10.5. Entropy

9.11. Novartis AG

9.11.1. Company Overview

9.11.2. Company Snapshot

9.11.3. Financial Overview

9.11.4. Product Listing

9.11.5. Entropy

9.12. BreatheSuite Inc.

9.12.1. Company Overview

9.12.2. Company Snapshot

9.12.3. Financial Overview

9.12.4. Product Listing

9.12.5. Entropy

9.13. Lupin

9.13.1. Company Overview

9.13.2. Company Snapshot

9.13.3. Financial Overview

9.13.4. Product Listing

9.13.5. Entropy

9.14. Personal Air Quality Systems Pvt Ltd (PAQS)

9.14.1. Company Overview

9.14.2. Company Snapshot

9.14.3. Financial Overview

9.14.4. Product Listing

9.14.5. Entropy

9.15. Biocorp

9.15.1. Company Overview

9.15.2. Company Snapshot

9.15.3. Financial Overview

9.15.4. Product Listing

9.15.5. Entropy

9.16. Cognita Labs

9.16.1. Company Overview

9.16.2. Company Snapshot

9.16.3. Financial Overview

9.16.4. Product Listing

9.16.5. Entropy

10. Project Approach

10.1. Secondary Sources

10.2. Primary Sources

10.3. Data Triangulation

10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: COVID-19 Impact Analysis on Smart Inhalers Market

Table 3: Smart Inhalers Market Analysis in Global (2018-2026)

Table 4: Smart Inhalers Market Analysis in Global by Product Type (2018-2026)

Table 5: Smart Inhalers Market Analysis in Global by Device Type (2018-2026)

Table 6: Smart Inhalers Market Analysis in Global by Indication (2018-2026)

Table 7: Smart Inhalers Market Analysis in Global by Geography (2018-2026)

Table 8: Smart Inhalers Market Analysis in North America (2018-2026)

Table 9: Smart Inhalers Market Analysis in North America by Product Type (2018-2026)

Table 10: Smart Inhalers Market Analysis in North America by Device Type (2018-2026)

Table 11: Smart Inhalers Market Analysis in North America by Indication (2018-2026)

Table 12: Smart Inhalers Market Analysis in North America by Country (2018-2026)

Table 13: Smart Inhalers Market Analysis in the US (2018-2026)

Table 14: Smart Inhalers Market Analysis in Canada (2018-2026)

Table 15: Smart Inhalers Market Analysis in Mexico (2018-2026)

Table 16: Smart Inhalers Market Analysis in Europe (2018-2026)

Table 17: Smart Inhalers Market Analysis in Europe by Product Type (2018-2026)

Table 18: Smart Inhalers Market Analysis in Europe by Device Type (2018-2026)

Table 19: Smart Inhalers Market Analysis in Europe by Indication (2018-2026)

Table 20: Smart Inhalers Market Analysis in Europe by Country (2018-2026)

Table 21: Smart Inhalers Market Analysis in France (2018-2026)

Table 22: Smart Inhalers Market Analysis in Germany (2018-2026)

Table 23: Smart Inhalers Market Analysis in the UK (2018-2026)

Table 24: Smart Inhalers Market Analysis in Italy (2018-2026)

Table 25: Smart Inhalers Market Analysis in Spain (2018-2026)

Table 26: Smart Inhalers Market Analysis in Russia (2018-2026)

Table 27: Smart Inhalers Market Analysis in Rest of Europe (2018-2026)

Table 28: Smart Inhalers Market Analysis in Asia-Pacific (2018-2026)

Table 29: Smart Inhalers Market Analysis in Asia-Pacific by Product Type (2018-2026)

Table 30: Smart Inhalers Market Analysis in Asia-Pacific by Device Type (2018-2026)

Table 31: Smart Inhalers Market Analysis in Asia-Pacific by Indication (2018-2026)

Table 32: Smart Inhalers Market Analysis in Asia-Pacific by Country (2018-2026)

Table 33: Smart Inhalers Market Analysis in China (2018-2026)

Table 34: Smart Inhalers Market Analysis in Japan (2018-2026)

Table 35: Smart Inhalers Market Analysis in India (2018-2026)

Table 36: Smart Inhalers Market Analysis in Australia (2018-2026)

Table 37: Smart Inhalers Market Analysis in South Korea (2018-2026)

Table 38: Smart Inhalers Market Analysis in Rest of Asia-Pacific (2018-2026)

Table 39: Smart Inhalers Market Analysis in Rest of World (2018-2026)

Table 40: Smart Inhalers Market Analysis in Rest of World by Product Type (2018-2026)

Table 41: Smart Inhalers Market Analysis in Rest of World by Device Type (2018-2026)

Table 42: Smart Inhalers Market Analysis in Rest of World by Indication (2018-2026)

Table 43: Smart Inhalers Market Analysis in Rest of World by Country (2018-2026)

Table 44: Smart Inhalers Market Analysis in Middle East (2018-2026)

Table 45: Smart Inhalers Market Analysis in Africa (2018-2026)

Table 46: Smart Inhalers Market Analysis in South America (2018-2026)

List of Figures



Figure 1: Competitive Analysis

Figure 2: COVID-19 Impact Analysis on Smart Inhalers Market

Figure 3: Smart Inhalers Market Analysis in Global (2018-2026)

Figure 4: Smart Inhalers Market Analysis in Global by Product Type (2018-2026)

Figure 5: Smart Inhalers Market Analysis in Global by Device Type (2018-2026)

Figure 6: Smart Inhalers Market Analysis in Global by Indication (2018-2026)

Figure 7: Smart Inhalers Market Analysis in Global by Geography (2018-2026)

Figure 8: Smart Inhalers Market Analysis in North America (2018-2026)

Figure 9: Smart Inhalers Market Analysis in North America by Product Type (2018-2026)

Figure 10: Smart Inhalers Market Analysis in North America by Device Type (2018-2026)

Figure 11: Smart Inhalers Market Analysis in North America by Indication (2018-2026)

Figure 12: Smart Inhalers Market Analysis in North America by Country (2018-2026)

Figure 13: Smart Inhalers Market Analysis in the US (2018-2026)

Figure 14: Smart Inhalers Market Analysis in Canada (2018-2026)

Figure 15: Smart Inhalers Market Analysis in Mexico (2018-2026)

Figure 16: Smart Inhalers Market Analysis in Europe (2018-2026)

Figure 17: Smart Inhalers Market Analysis in Europe by Product Type (2018-2026)

Figure 18: Smart Inhalers Market Analysis in Europe by Device Type (2018-2026)

Figure 19: Smart Inhalers Market Analysis in Europe by Indication (2018-2026)

Figure 20: Smart Inhalers Market Analysis in Europe by Country (2018-2026)

Figure 21: Smart Inhalers Market Analysis in France (2018-2026)

Figure 22: Smart Inhalers Market Analysis in Germany (2018-2026)

Figure 23: Smart Inhalers Market Analysis in the UK (2018-2026)

Figure 24: Smart Inhalers Market Analysis in Italy (2018-2026)

Figure 25: Smart Inhalers Market Analysis in Spain (2018-2026)

Figure 26: Smart Inhalers Market Analysis in Russia (2018-2026)

Figure 27: Smart Inhalers Market Analysis in Rest of Europe (2018-2026)

Figure 28: Smart Inhalers Market Analysis in Asia-Pacific (2018-2026)

Figure 29: Smart Inhalers Market Analysis in Asia-Pacific by Product Type (2018-2026)

Figure 30: Smart Inhalers Market Analysis in Asia-Pacific by Device Type (2018-2026)

Figure 31: Smart Inhalers Market Analysis in Asia-Pacific by Indication (2018-2026)

Figure 32: Smart Inhalers Market Analysis in Asia-Pacific by Country (2018-2026)

Figure 33: Smart Inhalers Market Analysis in China (2018-2026)

Figure 34: Smart Inhalers Market Analysis in Japan (2018-2026)

Figure 35: Smart Inhalers Market Analysis in India (2018-2026)

Figure 36: Smart Inhalers Market Analysis in Australia (2018-2026)

Figure 37: Smart Inhalers Market Analysis in South Korea (2018-2026)

Figure 38: Smart Inhalers Market Analysis in Rest of Asia-Pacific (2018-2026)

Figure 39: Smart Inhalers Market Analysis in Rest of World (2018-2026)

Figure 40: Smart Inhalers Market Analysis in Rest of World by Product Type (2018-2026)

Figure 41: Smart Inhalers Market Analysis in Rest of World by Device Type (2018-2026)

Figure 42: Smart Inhalers Market Analysis in Rest of World by Indication (2018-2026)

Figure 43: Smart Inhalers Market Analysis in Rest of World by Country (2018-2026)

Figure 44: Smart Inhalers Market Analysis in Middle East (2018-2026)

Figure 45: Smart Inhalers Market Analysis in Africa (2018-2026)

Figure 46: Smart Inhalers Market Analysis in South America (2018-2026)

Figure 47: Market Drivers

Figure 48: Market Barriers

Figure 49: Market Opportunities

Figure 50: PORTER's Five Force Analysis

Teva Pharmaceutical
AstraZeneca
GlaxoSmithKline plc.
AptarGroup, Inc.
Novartis AG
OPKO Health, Inc.
BreatheSuite Inc.
Adherium
Propeller Health
H&T Presspart Manufacturing Ltd.
Zeolr Technologies Pvt Ltd
Findair Sp. z o. o.
Lupin
Personal Air Quality Systems Pvt Ltd (PAQS)
Biocorp
Cognita Labs, and others.

 

  • Tags:
  • Smart Inhalers
  • Smart Inhalers Mechanism
  • Smart Inhalers Companies
  • Smart Inhalers Medical devices
  • Smart Inhalers Market
  • Smart Inhalers Industry
  • Smart Inhalers Market Size
  • Smart Inhalers Market Share
  • Smart Inhalers Companies
  • Smart Inhalers devices

Forward to Friend

Need A Quote